Clinical • Tumor mutational burden
|
TMB (Tumor Mutational Burden) • CDKN2A (Cyclin Dependent Kinase Inhibitor 2A) • RAF1 (Raf-1 Proto-Oncogene Serine/Threonine Kinase) • PRAME (Preferentially Expressed Antigen In Melanoma) • GOLGA4 (Golgin A4) • MLANA (Melan-A)
|
TMB-L • PRAME expression • GOLGA4-RAF1 fusion